173 related articles for article (PubMed ID: 37210448)
21. Predictors of Response and Survival in Locally Advanced Adenocarcinoma of the Pancreas Following Neoadjuvant GTX with or Without Radiation Therapy.
Sherman WH; Hecht E; Leung D; Chu K
Oncologist; 2018 Jan; 23(1):4-e10. PubMed ID: 29212734
[TBL] [Abstract][Full Text] [Related]
22. Pancreatic cancer: Open or minimally invasive surgery?
Zhang YH; Zhang CW; Hu ZM; Hong DF
World J Gastroenterol; 2016 Aug; 22(32):7301-10. PubMed ID: 27621576
[TBL] [Abstract][Full Text] [Related]
23. Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma.
Hu Q; Wang D; Chen Y; Li X; Cao P; Cao D
Radiat Oncol; 2019 Jul; 14(1):120. PubMed ID: 31291998
[TBL] [Abstract][Full Text] [Related]
24. The experience of the minimally invasive (MI) fellowship-trained (FT) hepatic-pancreatic and biliary (HPB) surgeon: could the outcome of MI pancreatoduodenectomy for peri-ampullary tumors be better than open?
Gumbs AA; Chouillard E; Abu Hilal M; Croner R; Gayet B; Gagner M
Surg Endosc; 2021 Sep; 35(9):5256-5267. PubMed ID: 33146810
[TBL] [Abstract][Full Text] [Related]
25. Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer.
Ferrone CR; Marchegiani G; Hong TS; Ryan DP; Deshpande V; McDonnell EI; Sabbatino F; Santos DD; Allen JN; Blaszkowsky LS; Clark JW; Faris JE; Goyal L; Kwak EL; Murphy JE; Ting DT; Wo JY; Zhu AX; Warshaw AL; Lillemoe KD; Fernández-del Castillo C
Ann Surg; 2015 Jan; 261(1):12-7. PubMed ID: 25599322
[TBL] [Abstract][Full Text] [Related]
26. Neoadjuvant chemoradiation is associated with decreased lymph node ratio in borderline resectable pancreatic cancer: A propensity score matched analysis.
Peng JS; Morris-Stiff G; Ali NS; Wey J; Chalikonda S; El-Hayek KM; Walsh RM
Hepatobiliary Pancreat Dis Int; 2021 Feb; 20(1):74-79. PubMed ID: 32861576
[TBL] [Abstract][Full Text] [Related]
27. Survival after Margin-Positive Resection in the Era of Modern Chemotherapy for Pancreatic Cancer: Do Patients Still Benefit?
Arrington AK; Hsu CH; Schaefer KL; O'Grady CL; Khreiss M; Riall TS
J Am Coll Surg; 2021 Jul; 233(1):100-109. PubMed ID: 33781861
[TBL] [Abstract][Full Text] [Related]
28. Impact of resection margin status on survival in pancreatic cancer patients after neoadjuvant treatment and pancreatoduodenectomy.
Maeda S; Moore AM; Yohanathan L; Hata T; Truty MJ; Smoot RL; Cleary SP; Nagorney DM; Grotz TE; Park EJ; Girgis MD; Reber HA; Motoi F; Masuda T; Unno M; Kendrick ML; Donahue TR
Surgery; 2020 May; 167(5):803-811. PubMed ID: 31992444
[TBL] [Abstract][Full Text] [Related]
29. [Standardization of pancreatic cancer specimen pathological examination].
Hlavsa J; Procházka V; Mazanec J; Hausnerová J; Pavlík T; Andrašina T; Novotný I; Penka I; Kala Z
Rozhl Chir; 2014 Mar; 93(3):132-8. PubMed ID: 24720716
[TBL] [Abstract][Full Text] [Related]
30. High-resolution pancreatic computed tomography for assessing pancreatic ductal adenocarcinoma resectability: a multicenter prospective study.
Lee DH; Ha HI; Jang JY; Lee JW; Choi JY; Bang S; Lee CH; Kim WB; Lee SS; Kim SC; Kang BK; Lee JM
Eur Radiol; 2023 Sep; 33(9):5965-5975. PubMed ID: 36988715
[TBL] [Abstract][Full Text] [Related]
31. Tumour origin and R1 rates in pancreatic resections: towards consilience in pathology reporting.
Bal M; Rane S; Talole S; Ramadwar M; Deodhar K; Patil P; Goel M; Shrikhande S
Virchows Arch; 2018 Sep; 473(3):293-303. PubMed ID: 30091124
[TBL] [Abstract][Full Text] [Related]
32. Relationship between surgical R0 resectability and findings of peripancreatic vascular invasion on CT imaging after neoadjuvant S-1 and concurrent radiotherapy in patients with borderline resectable pancreatic cancer.
Yasuta S; Kobayashi T; Aizawa H; Takahashi S; Ikeda M; Konishi M; Kojima M; Kuno H; Uesaka K; Morinaga S; Miyamoto A; Toyama H; Takakura N; Sugimachi K; Takayama W
BMC Cancer; 2020 Dec; 20(1):1184. PubMed ID: 33267820
[TBL] [Abstract][Full Text] [Related]
33. Practice variation in venous resection during pancreatoduodenectomy for pancreatic cancer: A nationwide cohort study.
Groen JV; Michiels N; Besselink MG; Bosscha K; Busch OR; van Dam R; van Eijck CHJ; Koerkamp BG; van der Harst E; de Hingh IH; Karsten TM; Lips DJ; de Meijer VE; Molenaar IQ; Nieuwenhuijs VB; Roos D; van Santvoort HC; Wijsman JH; Wit F; Zonderhuis BM; de Vos-Geelen J; Wasser MN; Bonsing BA; Stommel MWJ; Mieog JSD;
Surgery; 2023 Oct; 174(4):924-933. PubMed ID: 37451894
[TBL] [Abstract][Full Text] [Related]
34. [Radical procedures in patients with pancreatic cancer--impact on prolongation and quality of life].
Ryska M
Rozhl Chir; 2010 Dec; 89(12):725-30. PubMed ID: 21404511
[TBL] [Abstract][Full Text] [Related]
35. Margin status and long-term prognosis of primary pancreatic neuroendocrine tumor after curative resection: Results from the US Neuroendocrine Tumor Study Group.
Zhang XF; Wu Z; Cloyd J; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha F; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Smith PM; Cho C; Beems M; Schmidt CR; Dillhoff M; Maithel SK; Pawlik TM
Surgery; 2019 Mar; 165(3):548-556. PubMed ID: 30278986
[TBL] [Abstract][Full Text] [Related]
36. [R1 resection for pancreatic carcinoma].
Weber GF; Kersting S; Haller F; Grützmann R
Chirurg; 2017 Sep; 88(9):764-770. PubMed ID: 28653152
[TBL] [Abstract][Full Text] [Related]
37. Resection after neoadjuvant therapy for locally advanced, "unresectable" pancreatic cancer.
Strobel O; Berens V; Hinz U; Hartwig W; Hackert T; Bergmann F; Debus J; Jäger D; Büchler MW; Werner J
Surgery; 2012 Sep; 152(3 Suppl 1):S33-42. PubMed ID: 22770956
[TBL] [Abstract][Full Text] [Related]
38. Pancreatic Cancer Surgery: The New R-status Counts.
Strobel O; Hank T; Hinz U; Bergmann F; Schneider L; Springfeld C; Jäger D; Schirmacher P; Hackert T; Büchler MW
Ann Surg; 2017 Mar; 265(3):565-573. PubMed ID: 27918310
[TBL] [Abstract][Full Text] [Related]
39. Impact of Neoadjuvant Therapy on Survival Following Margin-Positive Resection for Pancreatic Cancer.
Chopra A; Zenati M; Hogg ME; Zeh HJ; Bartlett DL; Bahary N; Zureikat AH; Beane JD
Ann Surg Oncol; 2021 Nov; 28(12):7759-7769. PubMed ID: 34027585
[TBL] [Abstract][Full Text] [Related]
40. Safety and feasibility of minimally invasive gastrectomy during the early introduction in the Netherlands: short-term oncological outcomes comparable to open gastrectomy.
Brenkman HJF; Ruurda JP; Verhoeven RHA; van Hillegersberg R
Gastric Cancer; 2017 Sep; 20(5):853-860. PubMed ID: 28185027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
